Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection

EMBO Molecular Medicine(2023)10.15252/emmm.202317376Source: DataRank Database

Viral anti‐inflammatory serpin reduces immuno‐coagulopathic pathology in SARS‐CoV‐2 mouse models of infection is a research paper published in EMBO Molecular Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access12 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.00)OA: goldTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (32)

Yize Li ORCID,Karen V. Kibler ORCID,Simona Kraberger ORCID,Arvind Varsani ORCID,Julie Turk

Live enrichment

PubMed:37534622 PMC:PMC10493584 OpenAlex:https://openalex.org/W4385514954

HHS ¦ National Institutes of Health

Grant: NIH R01AR074627‐01A1

Mercatus Center Fast Grant

Grant: G09202‐300

NIAMS NIH HHS

Grant: R01 AR074627

NIAID NIH HHS

Grant: R01 AI080607

National Institutes of Health

Grant: 1R01AR074627-01A1

Bioengineered Skin Sealants

ASU Skysong Innovation Award

FWCI

2.00

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202317376

GOLDhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202317376

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202317376

publisherhttps://link.springer.com/content/pdf/10.15252/emmm.202317376.pdf

publisherhttps://link.springer.com/article/10.15252/emmm.202317376/fulltext.html

Fields of Study

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19MedicineBiology0303 health sciences03 medical and health sciencesMiceAnimalsHumansSerpinsSARS-CoV-2Post-Acute COVID-19 SyndromeCOVID-19Anti-Inflammatory AgentsDisease Models, AnimalPeptide HydrolasesRespiratory Distress Syndrome

MeSH Terms

COVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeAnimalsAnti-Inflammatory AgentsDisease Models, AnimalHumansPeptide HydrolasesRespiratory Distress SyndromeSerpinsMice

Keywords

SerpinARDSImmunologyProteasesMedicinePlasminogen activator inhibitor-1InflammationComplement systemPlasminogen activatorPlasminLungVirologyBiologyAntibodyInternal medicineComplementuPARSars-cov-2Medicine (General)Respiratory Distress SyndromeAnti-Inflammatory AgentsCOVID-19ArticlesQH426-470SARS‐CoV‐2MiceDisease Models, AnimalR5-920Post-Acute COVID-19 SyndromeGeneticsAnimalsHumansSerpinsPeptide Hydrolases

Sustainable Development Goals

SDG 0: Good health and well-being